Medstone International said it had “no idea”...
- Share via
Medstone International said it had “no idea” why its stock has lost 28% of its value in recent trading. Medstone, which makes a device that shatters kidney stones with shock waves, went public through a June stock offering at $13 a share. The stock soared to $42 a share before plunging as low as $26 last Friday. The stock closed Monday at $30 in over-the-counter trading.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.